Share:
Peer-Reviewed Publication
Radiother Oncol2025;212111110.November 1, 2025Journal Article

Predicting radiation pneumonitis in lung cancer patients using robust 4DCT-ventilation and perfusion imaging.

Taindra Neupane1, Edward Castillo2, Yingxuan Chen3, Soroush Heidari Pahlavian4, Richard Castillo5, Yevgeniy Vinogradskiy6, Wookjin Choi7
1Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States. Electronic address: taindra.neupane@jefferson.edu.
2Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, United States. Electronic address: edward.castillo@utexas.edu.
3Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States. Electronic address: yingxuan.chen@jefferson.edu.
4MIM Software Inc., Beachwood, OH, United States. Electronic address: spahlavian@mimsoftware.com.
5Department of Radiation Oncology, Emory University, Atlanta, GA, United States. Electronic address: edward.castillo@utexas.edu.
6Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States. Electronic address: yevgeniy.vinogradskiy@jefferson.edu.
7Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States. Electronic address: wookjin.choi@jefferson.edu.

Abstract

PURPOSE: Methods have been developed that apply image processing to 4-Dimension computed tomography (4DCT) to generate lung ventilation (4DCT-ventilation). Traditional methods for 4DCT-ventilation rely on density-change methods and lack reproducibility and do not provide 4DCT-perfusion data. Novel 4DCT-ventilation/perfusion methods have been developed that are robust and provide 4DCT-perfusion inf…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.